Slate Path Capital LP Buys Mylan NV, Ironwood Pharmaceuticals Inc, Pan American Silver Corp, Sells Snap Inc, The Medicines Co, EQT Corp

• New Purchases: MYL, IRWD, W, ATRA, CYCN, ARCH, RIG,
• Added Positions: PAAS, ENDP, GOLD, MOS, FCX, LX,
• Reduced Positions: SNAP, BHC, Z, NYT, KEX, ALNY, CHTR, CUE, APRN,
• Sold Out: MDCO, EQT, RETA, AG, TDW, X,

For the details of Slate Path Capital LP's stock buys and sells, go to https://www.gurufocus.com/guru/slate+path+capital+lp/current-portfolio/portfolio

1. Barrick Gold Corp (GOLD) - 10,145,000 shares, 14.25% of the total portfolio. Shares added by 3.57%
2. Charter Communications Inc (CHTR) - 376,000 shares, 12.58% of the total portfolio. Shares reduced by 1.31%
3. Mylan NV (MYL) - 10,785,000 shares, 12.33% of the total portfolio. New Position
4. New York Times Co (NYT) - 4,330,000 shares, 10.20% of the total portfolio. Shares reduced by 12.17%
5. Snap Inc (SNAP) - 9,585,000 shares, 8.74% of the total portfolio. Shares reduced by 33.92%

Slate Path Capital LP initiated holding in Mylan NV. The purchase prices were between $13.26 and $22.85, with an estimated average price of $19.25. The stock is now traded at around $15.16. The impact to a portfolio due to this purchase was 12.33%. The holding were 10,785,000 shares as of .

Slate Path Capital LP initiated holding in Ironwood Pharmaceuticals Inc. The purchase prices were between $8.58 and $14.01, with an estimated average price of $11.8. The stock is now traded at around $11.13. The impact to a portfolio due to this purchase was 1.04%. The holding were 1,340,000 shares as of .

Slate Path Capital LP initiated holding in Wayfair Inc. The purchase prices were between $23.52 and $109.87, with an estimated average price of $77.3. The stock is now traded at around $173.10. The impact to a portfolio due to this purchase was 0.29%. The holding were 70,000 shares as of .

Slate Path Capital LP initiated holding in Atara Biotherapeutics Inc. The purchase prices were between $5.69 and $17.78, with an estimated average price of $12.81. The stock is now traded at around $10.77. The impact to a portfolio due to this purchase was 0.27%. The holding were 420,000 shares as of .

Slate Path Capital LP initiated holding in Cyclerion Therapeutics Inc. The purchase prices were between $2.46 and $5.84, with an estimated average price of $3.56. The stock is now traded at around $3.85. The impact to a portfolio due to this purchase was 0.24%. The holding were 1,196,063 shares as of .

Slate Path Capital LP initiated holding in Arch Coal Inc. The purchase prices were between $27.32 and $73.54, with an estimated average price of $51.84. The stock is now traded at around $29.04. The impact to a portfolio due to this purchase was 0.04%. The holding were 18,000 shares as of .

Slate Path Capital LP added to a holding in Pan American Silver Corp by 23.06%. The purchase prices were between $11.77 and $25.34, with an estimated average price of $20.85. The stock is now traded at around $24.50. The impact to a portfolio due to this purchase was 0.91%. The holding were 4,430,000 shares as of .

Slate Path Capital LP added to a holding in Endo International PLC by 865.71%. The purchase prices were between $2.28 and $6.6, with an estimated average price of $5.09. The stock is now traded at around $3.81. The impact to a portfolio due to this purchase was 0.86%. The holding were 3,380,000 shares as of .

Slate Path Capital LP added to a holding in LexinFintech Holdings Ltd by 95.56%. The purchase prices were between $8.12 and $16.63, with an estimated average price of $12.43. The stock is now traded at around $8.24. The impact to a portfolio due to this purchase was 0.15%. The holding were 440,000 shares as of .

Slate Path Capital LP sold out a holding in The Medicines Co. The sale prices were between $84.9 and $84.96, with an estimated average price of $84.93.

Slate Path Capital LP sold out a holding in EQT Corp. The sale prices were between $4.96 and $10.9, with an estimated average price of $7.08.

Slate Path Capital LP sold out a holding in Reata Pharmaceuticals Inc. The sale prices were between $124.16 and $247.74, with an estimated average price of $194.02.

Slate Path Capital LP sold out a holding in Tidewater Inc. The sale prices were between $5.31 and $20.22, with an estimated average price of $13.67.

Slate Path Capital LP sold out a holding in First Majestic Silver Corp. The sale prices were between $5 and $12.26, with an estimated average price of $9.03.

Slate Path Capital LP sold out a holding in United States Steel Corp. The sale prices were between $4.9 and $11.41, with an estimated average price of $8.46.